Clinical Trial Update: A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2a study of monoclonal antibodies PGT121, VRC07-523LS, and PGDM1400 in both HIV-uninfected and HIV-infected adults completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• PGDM1400 (PGDM1400)
• PGT121 (PGT121)
• VRC07-523LS

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV/AIDS | Phase 1, Phase 2 | Status: COMPLETED